Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous
W G Brodbeck1, C Mold, J P Atkinson
1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Insights
Decay-accelerating factor (DAF) and membrane cofactor protein (MCP) work together to prevent complement system damage to self cells. DAF is essential for MCP to effectively cleave complement proteins, enhancing cellular protection.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Decay-accelerating factor (DAF or CD55) and membrane cofactor protein (MCP or CD46) protect self cells from complement activation.
- The cooperative mechanisms of DAF and MCP in regulating autologous complement remain unclear.
Purpose of the Study:
- To investigate the synergistic functions of DAF and MCP in regulating complement intermediates.
- To elucidate the cooperative mechanisms between DAF and MCP on cell surfaces.
Main Methods:
- Generated a GPI-anchored form of MCP for cell membrane incorporation.
- Utilized purified alternative pathway complement components and rabbit erythrocytes for quantitative assays.
- Examined complement intermediates with individual or combined DAF and MCP.
Main Results:
- DAF and MCP synergistically inhibit C3b deposition on cell surfaces.
- MCP's factor I-mediated C3b cleavage activity is inhibited by factors B and D.
- DAF restores MCP's C3b cleavage activity in the presence of factors B and D.
Conclusions:
- The combined action of DAF and MCP exceeds their individual contributions to complement regulation.
- DAF is crucial for MCP's function in cleaving cell-bound C3b, particularly when factors B and D are present.
- Findings have implications for xenotransplantation, inflammatory diseases, and tumor immune evasion.
Abstract:
Decay-accelerating factor (DAF or CD55) and membrane cofactor protein (MCP or CD46) function intrinsically in the membranes of self cells to prevent activation of autologous complement on their surfaces. How these two regulatory proteins cooperate on self-cell surfaces to inhibit autologous complement attack is unknown. In this study, a GPI-anchored form of MCP was generated. The ability of this recombinant protein and that of naturally GPI-anchored DAF to incorporate into cell membranes then was exploited to examine the combined functions of DAF and MCP in regulating complement intermediates assembled from purified alternative pathway components on rabbit erythrocytes. Quantitative studies with complement-coated rabbit erythrocyte intermediates constituted with each protein individually or the two proteins together demonstrated that DAF and MCP synergize the actions of each other in preventing C3b deposition on the cell surface. Further analyses showed that MCP's ability to catalyze the factor I-mediated cleavage of cell-bound C3b is inhibited in the presence of factors B and D and is restored when DAF is incorporated into the cells. Thus, the activities of DAF and MCP, when present together, are greater than the sum of the two proteins individually, and DAF is required for MCP to catalyze the cleavage of cell-bound C3b in the presence of excess factors B and D. These data are relevant to xenotransplantation, pharmacological inhibition of complement in inflammatory diseases, and evasion of tumor cells from humoral immune responses.
Related Concept Videos
Cofactors and Coenzymes
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Complement System
Cellular Injury V: Apoptosis and Autophagy


